Catheter Precision (VTAK) Cash from Investing Activities (2017 - 2026)
Catheter Precision's (VTAK) quarterly Cash from Investing Activities came in at -$1.3 million in Q1 2026, down 13090.0% year-on-year from N/an in Q1 2025, and down 705.05% on a QoQ basis from $218000.0 in Q4 2025.
Catheter Precision (VTAK) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Catheter Precision (VTAK) has 10 years of Cash from Investing Activities data on file, last reported at -$1.3 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 13090.0% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 1976.36% decrease from a year earlier, with the FY2025 full-year figure at $167000.0, up 349.25% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$1.3 million, down from $218000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for VTAK reached as high as $218000.0 in Q4 2025 and fell as low as -$1.3 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$104916.7 across 5 years, with a median of -$19000.0 in 2023.
- Across the five-year window, Cash from Investing Activities jumped 2200.0% in 2022 and plunged 13090.0% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at $21000.0 in 2022, then plunged by 185.71% to -$18000.0 in 2023, then slumped by 150.0% to -$45000.0 in 2024, then soared by 584.44% to $218000.0 in 2025, then tumbled by 705.05% to -$1.3 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$1.3 million in Q1 2026, $218000.0 in Q4 2025, and -$28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Catheter Precision | 635,411.82 | 235,411.82 | 390,000.00 | -1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32 Mn |
| Mar 31, 2026 | -1.32 Mn |
| Dec 31, 2025 | 218,000.00 |
| Dec 31, 2025 | 218,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Mar 31, 2024 | -22,000.00 |
| Mar 31, 2024 | -22,000.00 |
| Dec 31, 2023 | -18,000.00 |
| Dec 31, 2023 | -18,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -20,000.00 |